OmniAb, Inc., headquartered in the United States, is a leading biotechnology company specialising in the development of innovative antibody discovery platforms. Founded in 2018, OmniAb has rapidly established itself in the biopharmaceutical industry, focusing on providing unique solutions for therapeutic antibody development. The company’s core offerings include its proprietary OmniAb platform, which enables the generation of fully human antibodies with high specificity and affinity. This technology sets OmniAb apart, allowing for accelerated drug discovery processes and enhanced therapeutic efficacy. With a strong market position, OmniAb has achieved significant milestones, including strategic partnerships and collaborations that bolster its presence in major operational regions across North America and Europe. The company continues to drive advancements in antibody therapeutics, positioning itself as a key player in the evolving landscape of biomedicine.
How does OmniAb, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
OmniAb, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OmniAb, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. However, the company is likely aware of the growing importance of climate commitments within the biotechnology sector. In the absence of specific emissions data or reduction initiatives, it is essential for OmniAb to consider establishing measurable climate goals and aligning with industry standards to enhance their sustainability profile. This could involve setting science-based targets and participating in climate pledges to demonstrate their commitment to reducing carbon emissions in the future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OmniAb, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.